DCM
SRTAW

Difesa Capital Management’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Difesa Capital Management’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-219,875
Closed -$101K – 39
2023
Q1 		$101K Hold
219,875
– – 0.07% 78
2022
Q4 		$110K Hold
219,875
– – 0.09% 92
2022
Q3 		$141K Hold
219,875
– – 0.07% 103
2022
Q2 		$147K Hold
219,875
– – 0.08% 104
2022
Q1 		$446K Hold
219,875
– – 0.23% 98
2021
Q4 		$488K Buy
+219,875
New +$537K 0.33% 84

Other funds holding SRTAW

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Difesa Capital Management's SRTAW Position: Q2 2023 in Review

Difesa Capital Management sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q2 2023, closing a stake of 219,875 shares — an estimated $101K sold.

Difesa Capital Management first reported a position in SRTAW in Q4 2021 and held it in 6 quarters. The position peaked at $488K in Q4 2021. 10 funds tracked by Wall St. Rank hold SRTAW as of Q2 2023.

  • Difesa Capital Management reported no remaining Strata Critical Medical Inc Warrants position as of Q2 2023 after selling out during the quarter.
  • Difesa Capital Management sold 219,875 Strata Critical Medical Inc Warrants shares in Q2 2023, an estimated $101K.
  • Difesa Capital Management first reported a position in Strata Critical Medical Inc Warrants in Q4 2021 and held it in 6 quarters.
  • Difesa Capital Management's Strata Critical Medical Inc Warrants position peaked at $488K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q2 2023.

Based on Difesa Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.